Lung researchers at VUMC win prestigious fellowships

Two early-career faculty members in the Division of Allergy, Pulmonary and Critical Care Medicine, Scott McCall, MD, PhD, and Kevin Seitz, MD, MSc, have been awarded prestigious fellowships by the…

Read More

VUMC study takes closer look at how pulmonary fibrosis unfolds

The research study, co-authored by VUMC’s Jonathan Kropski, MD, could point to future therapeutic strategies that treat PF patients based on their individual stage of cellular and molecular…

Read More

Two VUMC physician-scientists named to medical honor society

Jonathan Kropski, MD, of the Pulmonary Fibrosis Research Group, has been elected to membership in the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most…

Read More

Study suggests a new way to treat incurable lung disease

IPF is one of the most common forms of pulmonary fibrosis, an interstitial lung disease characterized by the progressive accumulation of scar tissue (fibrosis) in the epithelial lining of the…

Read More

Studies to explore molecular drivers of pulmonary diseases

Three grants, totaling over $22 million, were awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute and will be led by a team of VUMC investigators.

Read More